Corrigendum to "MiR-23a-3p acts as an oncogene and potential prognostic biomarker by targeting PNRC2 in RCC" [Biomed. Pharmacother. 110 (2019) 656-666]
Biomed Pharmacother. 2019 Apr:112:108755.
doi: 10.1016/j.biopha.2019.108755.
Epub 2019 Mar 11.
1 Guangdong and Shenzhen Key Laboratory of Male Reproductive Medicine and Genetics, Peking University Shenzhen Hospital, Shenzhen, Guangdong, 518036, PR China; Clinical College, Peking University Shenzhen Hospital, Anhui Medical University, Hefei, Anhui, 230032, PR China.
2 Guangdong and Shenzhen Key Laboratory of Male Reproductive Medicine and Genetics, Peking University Shenzhen Hospital, Shenzhen, Guangdong, 518036, PR China.
3 Guangdong and Shenzhen Key Laboratory of Male Reproductive Medicine and Genetics, Peking University Shenzhen Hospital, Shenzhen, Guangdong, 518036, PR China; Clinical College, Peking University Shenzhen Hospital, Anhui Medical University, Hefei, Anhui, 230032, PR China. Electronic address: [email protected].